IR Calendar

Second Quarter 2025 Financial Results Conference Call

To ensure you are connected prior to the beginning of the call, BiomX suggests registering a minimum of 5 minutes before the start of the call.

2025 Annual Meeting of Stockholders

Biomed Israel 2025 Conference

First Quarter 2025 Financial Results Conference Call

Special Meeting of Stockholders

BiomX KOL Event

BiomX Announces Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)